Correlation Between Sabra Healthcare and BioNTech

Can any of the company-specific risk be diversified away by investing in both Sabra Healthcare and BioNTech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Sabra Healthcare and BioNTech into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Sabra Healthcare REIT and BioNTech SE, you can compare the effects of market volatilities on Sabra Healthcare and BioNTech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Sabra Healthcare with a short position of BioNTech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Sabra Healthcare and BioNTech.

Diversification Opportunities for Sabra Healthcare and BioNTech

-0.65

Correlation Coefficient

Sabra Healthcare  BioNTech

Excellent diversification

The 3 months correlation between Sabra and BioNTech is -0.65. Overlapping area represents the amount of risk that can be diversified away by holding Sabra Healthcare REIT and BioNTech SE in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on BioNTech SE and Sabra Healthcare is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Sabra Healthcare REIT are associated (or correlated) with BioNTech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of BioNTech SE has no effect on the direction of Sabra Healthcare i.e., Sabra Healthcare and BioNTech go up and down completely randomly.

Pair Corralation between Sabra Healthcare and BioNTech

Given the investment horizon of 90 days Sabra Healthcare REIT is expected to generate 0.51 times more return on investment than BioNTech. However, Sabra Healthcare REIT is 1.94 times less risky than BioNTech. It trades about 0.05 of its potential returns per unit of risk. BioNTech SE is currently generating about -0.07 per unit of risk. If you would invest  1,673  in Sabra Healthcare REIT on December 28, 2024 and sell it today you would earn a total of  81.00  from holding Sabra Healthcare REIT or generate 4.84% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Sabra Healthcare REIT  vs.  BioNTech SE

Sabra Healthcare REIT

Risk-Adjusted Performance

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Sabra Healthcare REIT are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. Despite somewhat strong basic indicators, Sabra Healthcare is not utilizing all of its potentials. The latest stock price disturbance, may contribute to short-term losses for the investors.

BioNTech SE

Risk-Adjusted Performance

Very Weak

Over the last 90 days BioNTech SE has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in April 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Pair Trading with Sabra Healthcare and BioNTech

The main advantage of trading using opposite Sabra Healthcare and BioNTech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Sabra Healthcare position performs unexpectedly, BioNTech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BioNTech will offset losses from the drop in BioNTech's long position.

The idea behind Sabra Healthcare REIT and BioNTech SE pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Top Crypto Exchanges module to search and analyze digital assets across top global cryptocurrency exchanges.